1. Home
  2. PCRX vs MXL Comparison

PCRX vs MXL Comparison

Compare PCRX & MXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • MXL
  • Stock Information
  • Founded
  • PCRX 2006
  • MXL 2003
  • Country
  • PCRX United States
  • MXL United States
  • Employees
  • PCRX N/A
  • MXL N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • MXL Semiconductors
  • Sector
  • PCRX Health Care
  • MXL Technology
  • Exchange
  • PCRX Nasdaq
  • MXL Nasdaq
  • Market Cap
  • PCRX 1.2B
  • MXL 1.2B
  • IPO Year
  • PCRX 2011
  • MXL 2010
  • Fundamental
  • Price
  • PCRX $22.76
  • MXL $17.41
  • Analyst Decision
  • PCRX Buy
  • MXL Buy
  • Analyst Count
  • PCRX 5
  • MXL 8
  • Target Price
  • PCRX $32.40
  • MXL $20.93
  • AVG Volume (30 Days)
  • PCRX 479.4K
  • MXL 1.2M
  • Earning Date
  • PCRX 11-05-2025
  • MXL 10-23-2025
  • Dividend Yield
  • PCRX N/A
  • MXL N/A
  • EPS Growth
  • PCRX N/A
  • MXL N/A
  • EPS
  • PCRX N/A
  • MXL N/A
  • Revenue
  • PCRX $705,848,000.00
  • MXL $378,015,000.00
  • Revenue This Year
  • PCRX $7.36
  • MXL $28.85
  • Revenue Next Year
  • PCRX $10.07
  • MXL $17.69
  • P/E Ratio
  • PCRX N/A
  • MXL N/A
  • Revenue Growth
  • PCRX 2.25
  • MXL N/A
  • 52 Week Low
  • PCRX $16.00
  • MXL $8.35
  • 52 Week High
  • PCRX $27.64
  • MXL $25.73
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 35.28
  • MXL 58.53
  • Support Level
  • PCRX $24.31
  • MXL $14.36
  • Resistance Level
  • PCRX $26.05
  • MXL $17.83
  • Average True Range (ATR)
  • PCRX 0.82
  • MXL 0.97
  • MACD
  • PCRX -0.20
  • MXL 0.12
  • Stochastic Oscillator
  • PCRX 18.36
  • MXL 87.75

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

Share on Social Networks: